Join Professor Stegenga for a discussion about how we can address medical intervention harms, which are often underestimated throughout the clinical trial process.
This engaging webinar will kick off a series of cross-Canada events focused on using lab tests appropriately.
With a significant number of medical decisions being influenced by lab test results, governments, health care administrators, and clinical and lab associations are turning their focus to…
Join Dr. Stirling Bryan for a discussion about important considerations related to value and the reimbursement of high-cost health technologies.
Join Assistant Professor Marc-André Gagnon for an engaging discussion about the challenges of the hybrid prescription drug system and how implementing practical reforms would result in improving access.
Dr. Brian O’Rourke is a featured speaker at the Conference Board of Canada’s annual health summit. He will share his perspective on “Putting Innovation Into Action,” and introduce a panel discussion that will explore the gap between innovation and implementation in Canadian health care.
More…
WEDNESDAY, OCTOBER 8, 2014 1:00 p.m. - 4:00 p.m.
Presentation slides now available
This event will provide an opportunity for pharmaceutical manufacturers and consultants who prepare CDR submissions on their behalf to receive an update on recent initiatives including:
application fees
performance…
Join Professor Annette Braunack-Mayer to hear her insights about the use of citizens’ juries in health policy decision-making.
Join Professor Christopher McCabe for a candid discussion about how linking reimbursement to health technology performance results in improved health outcomes and resource savings.
The Toronto Health Economics and Technology Assessment Collaborative (THETA) at the University of Toronto, together with the Maritime Strategy for Patient-Oriented Research (SPOR) SUPPORT Unit (MSSU) at Dalhousie University, will host the 2014 Health Technology Assessment Institute for Decision…
Join Dr. Yvonne Bombard — a rising star in Canadian health research — for her insights on the increasing enthusiasm for genomics and its promise in advancing personalized medicine.